Inovio Pharma (INO) Misses Q4 EPS by $1.13
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.29 +4.03%
EPS Growth %: +75.9%
Financial Fact:
Net loss/ (gain) attributable to non-controlling interest: 0
Today's EPS Names:
NEOV, MANU, CTAS, More
EPS Growth %: +75.9%
Financial Fact:
Net loss/ (gain) attributable to non-controlling interest: 0
Today's EPS Names:
NEOV, MANU, CTAS, More
Join SI Premium – FREE
Inovio Pharma (NASDAQ: INO) reported Q4 EPS of ($1.45), $1.13 worse than the analyst estimate of ($0.32). Revenue for the quarter came in at $1.77 million versus the consensus estimate of $2.84 million.
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- DAM Capital Starts Centum Electronics (CTE:IN) at Buy
- Jefferies Starts Frencken Group Ltd. (FRKN:SP) at Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
